Standard of care in advanced HIV disease: review of HIV treatment guidelines in sub-Saharan African countries-an extension study of eight countries

被引:0
作者
Scheier, Thomas C. [1 ,2 ]
Tufa, Tafese Beyene [3 ,4 ,5 ]
Feldt, Torsten [4 ,5 ]
Minga, Albert [7 ]
Hardy, Yasmine [6 ]
Moh, Raoul [8 ,9 ]
Damasceno, Albertino [10 ]
Chambal, Lucia [10 ,11 ]
Ntoumi, Francine [12 ,13 ]
Kades, Carine [12 ]
Bitunguhari, Leopold [14 ,15 ]
Sebatunzi, Osee R. [14 ,15 ]
Missanga, Marco [16 ]
Njekwa, Katanekwa [17 ]
Muyoyeta, Monde [17 ,18 ]
Rangarajan, Sumathy [1 ,2 ]
Meintjes, Graeme [19 ,20 ,21 ]
Mertz, Dominik [1 ,2 ,22 ,23 ]
Eikelboom, John W. [1 ,2 ]
Wasserman, Sean [19 ,24 ]
机构
[1] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[2] Hamilton Hlth Sci, Hamilton, ON, Canada
[3] Arsi Univ, Asella Referral & Teaching Hosp, Coll Hlth Sci, POB 04, Asella, Ethiopia
[4] Heinrich Heine Univ, Hirsch Inst Trop Med HITM, POB 04, Asella, Ethiopia
[5] Univ Hosp Dusseldorf UKD, Dept Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany
[6] Komfo Anokye Teaching Hosp, Directorate Med, Kumasi, Ghana
[7] Ctr Med Suivi Donneurs Sang CMSDS CNTSCI, Abidjan, Cote Ivoire
[8] Programme PAC CI, Site ANRS Cote Ivoire, Abidjan, Cote Ivoire
[9] Univ Felix Houphouet Boigny, Unite Pedag Dermatol & Infectiol, Abidjan, Cote Ivoire
[10] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique
[11] Maputo Cent Hosp, Maputo, Mozambique
[12] Fdn Congolaise Rech Med, Brazzaville, Rep Congo
[13] Univ Tubingen, Inst Trop Med, Tubingen, Germany
[14] Univ Teaching Hosp Kigali, Dept Internal Med, Kigali, Rwanda
[15] Univ Rwanda, Sch Med & Pharm, Dept Internal Med, Kigali, Rwanda
[16] NIMR Mbeya Med Res Ctr, Mbeya, Tanzania
[17] Ctr Infect Dis Res Zambia CIDRZ, POB 34681, Lusaka 10101, Zambia
[18] Ctr Infect Dis Res, POB 34681, Lusaka 10101, Zambia
[19] Univ Cape Town, Inst Infect Dis & Mol Med, Ctr Infect Dis Res Africa,Observ, Wellcome Discovery Res Platforms Infect, Cape Town, South Africa
[20] Univ Cape Town, Dept Med, Cape Town, South Africa
[21] Queen Mary Univ London, Blizard Inst, London, England
[22] McMaster Univ, Dept Med, Div Infect Dis, Hamilton, ON, Canada
[23] McMaster Univ, Fac Hlth Sci, Dept Hlth Res Methodol Evidence & Impact, Hamilton, ON, Canada
[24] City St Georges Univ London, Inst Infect & Immun, London, England
来源
AIDS RESEARCH AND THERAPY | 2025年 / 22卷 / 01期
基金
比尔及梅琳达.盖茨基金会; 美国国家卫生研究院; 英国惠康基金;
关键词
Advanced HIV disease; Guidelines; Sub-Saharan Africa; Antiretroviral therapy; STARTING ANTIRETROVIRAL THERAPY; HIV-1-INFECTED PATIENTS; MORTALITY; PROPHYLAXIS; INFECTION; MORBIDITY;
D O I
10.1186/s12981-025-00733-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
IntroductionThe World Health Organization (WHO) has published guidelines for the management of patients with advanced HIV disease (AHD) but mortality remains high. Adoption of WHO recommendations by national guidelines is poorly documented. We aimed to extend our prior review of six national management guidelines by including additional countries from sub-Saharan Africa.MethodsWe identified guidelines of eight additional countries participating in a multicountry trial of azithromycin prophylaxis for AHD. Data was extracted in five domains including definition of AHD (1 item), screening (6 items), prophylaxis (6 items), supportive care (1 items), and HIV treatment (4 items) and scored agreement of each national guideline with the WHO guidelines.ResultsSix of the eight national guidelines had a designated section for AHD. Compared with the WHO guideline, the agreement score for national guidelines was between 7 and 17 out of 18, whereby disagreement is mainly driven by missing information. None of the national guidelines had more than three items not in agreement with the WHO guidelines, and the maximum number of items not addressed by any one guideline was eight. Main areas of disagreement were the targeted population for start of ART in presence of tuberculosis meningitis (1/8 in agreement) and urine lipoarabinomannan screening (2/8 in agreement). The targeted population group for cotrimoxazole prophylaxis and its discontinuation was in line with the WHO recommendations in 3/8 national guidelines. Except one guideline, all documents showed similar overall agreement, irrespectively of publication date.ConclusionNational guidelines for the management of people with AHD are broadly in agreement with WHO guidelines. Main areas of disagreement are recommendations regarding urine lipoarabinomannan screening, cotrimoxazole prophylaxis and start of antiretroviral therapy in presence of tuberculosis.
引用
收藏
页数:10
相关论文
共 29 条
  • [1] [Anonymous], 2017, Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy
  • [2] [Anonymous], 2016, WHO Guidelines Approved by the Guidelines Review Committee, V2nd
  • [3] Prediction of CD4 T-Lymphocyte Count Using WHO Clinical Staging among ART-Naive HIV-Infected Adolescents and Adults in Northern Ethiopia: A Retrospective Study
    Aregay, Abraham Desta
    Kidane, Kibriti Mehari
    Aregay, Asfawosen Berhe
    Fenta, Kiros Ajemu
    Woldegebriel, Ataklti Gebretsadik
    Godefay, Hagos
    Woldearegay, Tewolde Wubayehu
    [J]. AIDS RESEARCH AND TREATMENT, 2020, 2020
  • [4] Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
    Boulware, David R.
    Meya, David B.
    Muzoora, Conrad
    Rolfes, Melissa A.
    Hullsiek, Katherine Huppler
    Musubire, Abdu
    Taseera, Kabanda
    Nabeta, Henry W.
    Schutz, Charlotte
    Williams, Darlisha A.
    Rajasingham, Radha
    Rhein, Joshua
    Thienemann, Friedrich
    Lo, Melanie W.
    Nielsen, Kirsten
    Bergemann, Tracy L.
    Kambugu, Andrew
    Manabe, Yukari C.
    Janoff, Edward N.
    Bohjanen, Paul R.
    Meintjes, Graeme
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (26) : 2487 - 2498
  • [5] Addressing advanced HIV disease and mortality in global HIV programming
    Boyd, Andrew T.
    Oboho, Ikwo
    Paulin, Heather
    Ali, Hammad
    Godfrey, Catherine
    Date, Anand
    Cavanaugh, J. Sean
    [J]. AIDS RESEARCH AND THERAPY, 2020, 17 (01)
  • [6] The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy
    Calmy, Alexandra
    Ford, Nathan
    Meintjes, Graeme
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 : S103 - S105
  • [7] Consolidated Guidelines on HIV Prevention, 2021, Testing, treatment, service delivery and monitoring: recommendations for a public health approach
  • [8] Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies
    Egger, M
    May, M
    Chêne, G
    Phillips, AN
    Ledergerber, B
    Dabis, F
    Costagliola, D
    Monforte, AD
    de Wolf, F
    Reiss, P
    Lundgren, JD
    Justice, AC
    Staszewski, S
    Leport, C
    Hogg, RS
    Sabin, CA
    Gill, MJ
    Salzberger, B
    Sterne, JAC
    [J]. LANCET, 2002, 360 (9327) : 119 - 129
  • [9] The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings
    Ehrenkranz, Peter D.
    Baptiste, Solange L.
    Bygrave, Helen
    Ellman, Tom
    Doi, Naoko
    Grimsrud, Anna
    Jahn, Andreas
    Kalua, Thokozani
    Nyirenda, Rose Kolola
    Odo, Michael O.
    Ondoa, Pascale
    Vojnov, Lara
    Holmes, Charles B.
    [J]. PLOS MEDICINE, 2019, 16 (05)
  • [10] Advanced HIV as a Neglected Disease
    Ford, Nathan
    Ehrenkranz, Peter
    Jarvis, Joseph
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (06) : 487 - 489